Achalasia: A New Clinically Relevant Classification by High-Resolution Manometry

Northwestern University, The Feinberg School of Medicine, Department of Medicine, Chicago, Illinois, USA.
Gastroenterology (Impact Factor: 13.93). 08/2008; 135(5):1526-33. DOI: 10.1053/j.gastro.2008.07.022
Source: PubMed

ABSTRACT Although the diagnosis of achalasia hinges on demonstrating impaired esophagogastric junction (EGJ) relaxation and aperistalsis, 3 distinct patterns of aperistalsis are discernable with high-resolution manometry (HRM). This study aimed to compare the clinical characteristics and treatment response of these 3 subtypes.
One thousand clinical HRM studies were reviewed, and 213 patients with impaired EGJ relaxation were identified. These were categorized into 4 groups: achalasia with minimal esophageal pressurization (type I, classic), achalasia with esophageal compression (type II), achalasia with spasm (type III), and functional obstruction with some preserved peristalsis. Clinical and manometric variables including treatment response were compared among the 3 achalasia subtypes. Logistic regression analysis was performed using treatment success as the dichotomous dependent variable controlling for independent manometric and clinical variables.
Ninety-nine patients were newly diagnosed with achalasia (21 type I, 49 type II, 29 type III), and 83 of these had sufficient follow-up to analyze treatment response. Type II patients were significantly more likely to respond to any therapy (BoTox [71%], pneumatic dilation [91%], or Heller myotomy [100%]) than type I (56% overall) or type III (29% overall) patients. Logistic regression analysis found type II to be a predictor of positive treatment response, whereas type III and pretreatment esophageal dilatation were predictive of negative treatment response.
Achalasia can be categorized into 3 subtypes that are distinct in terms of their responsiveness to medical or surgical therapies. Utilizing these subclassifications would likely strengthen future prospective studies of treatment efficacy in achalasia.

Download full-text


Available from: Peter J Kahrilas, Jul 07, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A 65-year-old woman, affected by Type II diabetes mellitus with no history of cardiac illness, referred to our hospital with a suspected diagnosis of “angina pectoris” for a cardiovascular evaluation. The patient's physical examination was unremarkable and cardiac laboratory tests, electrocardiogramand transthoracic echocardiogram were also normal. A standard chest X-ray revealed an ambiguous cor bovinum-like mediastinal image constituted of dilated thoracic esophagus profile. At upper gastrointestinal endoscopy any malignancies were ruled out and in-esophagus food stagnation with difficult crossing through the esophagogastric junction was assessed. A diagnosis of esophageal achalasia was suggested and then confirmed by high resolution manometry as the type 2 esophageal achalasia according to Chicago classification . The patient underwent a laparoscopic Heller's myotomy with Dor fundoplication, and at follow-up 12 months later she remained completely asymptomatic.
    European Journal of Internal Medicine 01/2015; DOI:10.1016/j.ejim.2014.12.005 · 2.30 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Achalasia is an esophagealmotility disorder that leads to dysphagia, chest pain, and weight loss. Its diagnosis is clinically suspected and is confirmed with esophageal manometry. Although pneumatic dilation has a role in the treatment of patients with achalasia, laparoscopic Hellermyotomy is considered bymany experts as the best treatment modality formost patients with newly diagnosed achalasia. This review will focus on the surgical treatment of achalasia, with special emphasis on laparoscopic Heller myotomy.We will also present a brief discussion of the evaluation of patients with persistent or recurrent symptoms after surgical treatment for achalasia and emerging technologies such as LESS, robot-assisted myotomy, and POEM.
    Gastroenterology Research and Practice 10/2013; 2013. DOI:10.1155/2013/708327 · 1.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pneumatic dilation of achalasia has a same medium-term efficacy than surgery and is commonly proposed as the first-line treatment. Intra-sphincteric injection of botulinum toxin is reserved for elderly patients with serious comorbidities. Per-endoscopic myotomy is possible but needs to be evaluated by further studies. Laparoscopic Heller's myotomy in first intension is reserved for young patients less than 40 years. Results of Heller's myotomy are not modified by prior endoscopic treatment or by mega-esophagus. Better surgery results are shown in recent and severe achalasia.
    La Presse Médicale 09/2012; · 1.17 Impact Factor